• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


intraFUSION









Just got called last week to meet with our lawyers. I'm a little worried for my RD, it sounds like he might be the scapegoat. Oh well, there's another just like him ready to take his place. The investigation should make life a bit more interesting.